Impact of vitamin D3 intake on hemoglobin levels and erythropoietin response in patients on hemodialysis: a randomized single blinded trial

Abstract Purpose Patients on regular hemodialysis (HD) are at the highest risk of developing anemia. Vitamin D deficiency is more prevalent in HD patients. Recent studies have suggested that improving vitamin D status can reduce both anemia and the need for higher recombinant human erythropoietin (E...

Full description

Bibliographic Details
Published in:	Future Journal of Pharmaceutical Sciences
Main Authors:	Mona Alshahawey, Lamia Mohamed El Wakeel, Tamer Wahid Elsaid, Nagwa Ali Sabri, Radwa Maher Elborolossy
Format:	Article
Language:	English
Published:	SpringerOpen 2025-09-01
Subjects:	Cholecalciferol Anemia Hemodialysis Erythropoietin Hemoglobin Ferritin
Online Access:	https://doi.org/10.1186/s43094-025-00881-9

Similar Items

Cholecalciferol effect on oxidative stress and novel predictors of inflammation in hemodialysis patients: a prospective randomized trial
by: Mona Alshahawey, et al.
Published: (2024-09-01)

Correlation between ultrafiltration rate and hemoglobin level and erythropoietin response in hemodialysis patients
by: Li Cui, et al.
Published: (2024-12-01)

Erythropoietin, ferritin, haptoglobin, hemoglobin and transferrin receptor in metabolic syndrome: a case control study
by: Hämäläinen Päivi, et al.
Published: (2012-09-01)

Erythropoietin resistance in patients with regular hemodialysis in Sohag university hospital
by: Nagwa S. Ahmed, et al.
Published: (2023-02-01)

Evaluation of Erythropoietin Stimulating Agent’s Responsiveness and Associated Factors in Hemodialysis Patients with Anemia
by: Salar Ahmed Alzubaidy, et al.
Published: (2024-09-01)

Difference in the Levels of Ferritin, Hemoglobin, and Erythrocyte Count of Stage 5 Chronic Kidney Disease Patients after One, Three and Six Months of Hemodialysis
by: Subur Wibowo, et al.
Published: (2019-07-01)

The Effects of Erythropoietin in the Management of Anemia of Chronic Renal Failure in Patients on Hemodialysis
by: M Rahimian, et al.
Published: (2005-04-01)

Efficacy and safety of subcutaneous administration of lyophilized powder of alfa-erythropoietin to maintain hemoglobin concentrations among hemodialysis patients
by: Satirapoj B, et al.
Published: (2017-09-01)

Erythropoietin hyporesponsiveness among egyptian hemodialysis patients
by: Salah Eldin Khedr PhD, et al.
Published: (2017-06-01)

Influence of hemoglobin level and dose of administered recombinant human beta erythropoietin on survival of hemodialysis patients
by: Knežević Violeta, et al.
Published: (2011-01-01)

Efficacy of L-carnitine combined with erythropoietin in the treatment of hemodialysis-induced renal anemia
by: ZHANG Yong, et al.
Published: (2018-01-01)

The Frequency of Resistance to Synthetic Erythropoietin and Its Risk Factors among Chronic Hemodialysis Patients in Kerman
by: Abbas Etminan, et al.
Published: (2018-01-01)

HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Sofia Omari, et al.
Published: (2011-05-01)

HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Alhossain A. Khalafallah, et al.
Published: (2011-01-01)

Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin
by: Ailema González-Ortiz, et al.
Published: (2019-08-01)

Does erythropoietin therapy affect circulating endothelial cells in hemodialysis patients?
by: T. Bulduk, et al.
Published: (2020-10-01)

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients
by: Maryam Rahbar, et al.
Published: (2017-01-01)

Impact of erythropoietin on anemia in end-stage renal disease patients on hemodialysis
by: Bashaer M Muhammad-Baqir, et al.
Published: (2023-01-01)

Effect of Tumor Necrosis Factor-Alpha on Erythropoietinand Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β Thalassemia/Hemoglobin E Patients
by: Dalina I Tanyong, et al.
Published: (2015-12-01)

The role of erythropoietins in cancer therapy
by: O. E. Kondratieva, et al.
Published: (2018-07-01)

The influencing factors of the erythropoietin resistance index and its association with all-cause mortality in maintenance hemodialysis patients
by: Xinju Zhao, et al.
Published: (2024-12-01)

Association of Erythropoietin, Adiponectin and Leptin levels with Anemia in uremic diabetic patients (Under hemodialysis):
by: Salim M. Al-Rubaâe, et al.
Published: (2011-01-01)

The relationship between the dose of continuous erythropoietin receptor activator and oxidative stress in hemodialysis patients
by: N. Stepanova, et al.
Published: (2018-09-01)

A multicenter descriptive analysis of anemia management in hemodialysis patients and its association with quality of life
by: Samah W. Al-Jabi, et al.
Published: (2023-06-01)

Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multicenter Cross-Sectional Study
by: Yasuhiro Mochida, et al.
Published: (2022-08-01)

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up
by: Antonio Lacquaniti, et al.
Published: (2020-09-01)

Anemia of Chronic Kidney Disease—A Narrative Review of Its Pathophysiology, Diagnosis, and Management
by: Krzysztof Badura, et al.
Published: (2024-05-01)

The combination of vitamin D3 and erythropoietin alleviates acute kidney injury induced by ischemia-reperfusion via inhibiting inflammation and apoptosis
by: Longyan Qin, et al.
Published: (2021-02-01)

Erythropoietin treatment and osteoporotic fracture risk in hemodialysis patients: A nationwide population-based study
by: Ching-Yu Lee, et al.
Published: (2024-12-01)

Positive association of residual kidney function with hemoglobin level in patients on peritoneal dialysis independent of endogenous erythropoietin concentration
by: Kazuhiko Tsuruya, et al.
Published: (2017-11-01)

Effects of faeces bombycis extract in treatment of erythropoietin resistance in hemodialysis patients based on the mechanism of Hepcidin regulating iron metabolism
by: JIN Hua, et al.
Published: (2016-01-01)

Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients
by: Mi Yeon Jung, et al.
Published: (2015-03-01)

Quality of Life and Hemoglobin Levels of Hemodialysis Patient at Siriraj Hospital
by: Tanita Thaweethamcharoen, et al.
Published: (2020-04-01)

Differences Ret-He, Reticulocyte, and Hemoglobin Levels Pre and Post Administration of Erythropoietin in Patients With Chronic Kidney Disease Undergoing Hemodialysis
by: Eko Hendry LUKITO, et al.
Published: (2024-08-01)

A randomized controlled trial of cholecalciferol supplementation in patients on maintenance hemodialysis
by: Beena Bansal, et al.
Published: (2014-01-01)

Haematological Indicators of Response to Erythropoietin Therapy in Chronic Renal Failure Patients on Haemodialysis: Impact of Angiotensin-Converting Enzyme rs4343 Gene Polymorphism
by: Hamdan Almaeen A, et al.
Published: (2021-08-01)

Evaluating the effect of thyroid disorders in hemodialysis patients
by: Mahshad Rahimi, et al.
Published: (2024-07-01)

Correlation between Systemic Immune-inflammation Index and Erythropoietin Hypo-responsiveness in Patients with Maintenance Hemodialysis
by: NIU Di, CHEN Ruifang, PANG Xinxin, XIAO Mingzhi, ZHANG Junshao, ZHANG Xiaowei
Published: (2024-10-01)

The Adverse Reactions of Erythropoietin in Methanol Toxicity: A Descriptive Study
by: Vahidreza Mohebpour, et al.
Published: (2024-02-01)

Concordance between Reticulocyte Hemoglobin Equivalent and Reticulocyte Hemoglobin Content in CKD Patients Undergoing Hemodialysis
by: Riadi Wirawan, et al.
Published: (2017-05-01)